Patrizia Farina
Marseille, 13005, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Coping strategies and quality of life: a longitudinal study of high-grade glioma patient-caregiver dyads.
Journal: Health and quality of life outcomes
Published: January 08, 2018
Relationship between magnetic resonance imaging characteristics and plasmatic levels of MMP2 and MMP9 in patients with recurrent high-grade gliomas treated by Bevacizumab and Irinotecan.
Journal: Journal of neuro-oncology
Published: June 07, 2016
Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life.
Journal: Journal of neuro-oncology
Published: January 29, 2016
Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma.
Journal: Cancer investigation
Published: January 07, 2016
MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma.
Journal: Neuro-oncology
Published: July 05, 2015
Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: an overview of the literature.
Journal: Cancer treatment reviews
Published: April 18, 2014
The combination of carmustine wafers and fotemustine in recurrent glioblastoma patients: a monoinstitutional experience.
Journal: BioMed research international
Published: March 12, 2014
Treatment of malignant gliomas in elderly patients: a concise overview of the literature.
Journal: BioMed research international
Published: February 14, 2014
An overview of fotemustine in high-grade gliomas: from single agent to association with bevacizumab.
An overview of fotemustine in high-grade gliomas: from single agent to association with bevacizumab.
Journal: BioMed research international
Published: February 12, 2014
Last Updated: 09/26/2026